Feedback / Questions
onvansertib (PCM-075) - Cardiff Oncology
https://www.globenewswire.com/news-release/2026/05/21/3299771/0/en/Cardiff-Oncology-Announces-Webcast-to-Discuss-Updated-Phase-2-CRDF-004-Data-for-Onvansertib-in-First-Line-RAS-Mutated-mCRC.html
May 21, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next